Mothers' age at menopause may predict daughters' ovarian reserve

A mother's age at menopause may predict her daughter's fertility in terms of the numbers of eggs remaining in her ovaries, according to the new research published online in Europe's leading reproductive medicine journal Human Reproduction today.

By assessing with two accepted methods – levels of anti-Müllerian hormone (AMH) and antral follicle count (AFC) – in daughters and comparing it with the of menopause in their , researchers found that both AMH and AFC declined faster in women whose mothers had an compared to women whose mothers had a late menopause. The number of eggs remaining in a woman's ovary is related to a reduction in her ability to conceive naturally, with both the number and quality of eggs starting to decline as she gets older.

Dr. Janne Bentzen from the Copenhagen University Hospital, Rigshospitalet, in Copenhagen, Denmark, who led the research, said: "This is the first study to suggest that the age-related decline of AMH and AFC may differ between those whose mothers entered menopause before the age of 45 years and those whose mothers entered menopause after the age of 55 years. Our findings support the idea that the ovarian reserve is influenced by hereditary factors. However, long-term follow-up studies are required. Conclusive evidence can only be obtained when we have longitudinal studies that follow women who have AMH measurements over time until menopause. Therefore, interpretations of our data are limited and the findings we have described may not occur in any given individual."

Previous research has suggested that there is about 20 years between a woman's fertility starting to decline and the . So a woman who enters the menopause at 45 may have experienced a decline in her fertility at the age of 25. Dr Bentzen said: " have established a link between the age at menopause among mothers and daughters. In line with the suggested 20-year interval between the first decline in fertility and the menopause, we hypothesised that maternal factors may also have an impact on a woman's fertility potential in terms of ovarian reserve."

The researchers recruited 527 women working in health care at the Copenhagen University Hospital, who were aged between 20-40 years and whose mothers' age at natural menopause was known. They divided them into three categories: those whose mothers had an early menopause (younger than 45); normal maternal age at menopause (46-54 years); and late maternal age at menopause (older than 55).

They used transvaginal sonography to count the number of antral follicles in the women's . Follicles are clusters of cells that contain the immature egg. Every woman is born with about two million of them, but only 400 will ever mature enough to release an egg for fertilisation during a woman's reproductive lifespan. Levels of AMH were measured from blood samples. The researchers also took a medical history, including details of smoking habits in mothers and daughters, oral contraceptive use and body mass index (BMI).

After adjusting for various factors that could affect the results (e.g. smoking, contraceptive use, age and BMI), they found that average AMH levels declined by 8.6%, 6.8% and 4.2% a year in the groups of women with mothers who had early, normal or late menopauses respectively. A similar pattern was seen for AFC, with annual declines of 5.8%, 4.7% and 3.2% in the same groups respectively.

The study also found that AMH levels and AFC were significantly lower (27.3% and 26.8% lower respectively) in oral contraceptive users compared with non-users. AFC in women whose mothers smoked while they were pregnant was an average of 11% lower, but there was no significant effect on AMH levels.

Dr. Bentzen said the effect of oral contraceptive use was likely to be temporary and unlikely to influence the long-term decline in ovarian follicles. However, she said clinicians and women should be aware of it when considering women's reproductive life spans or any fertility treatments. "We believe there is a need for longitudinal, large studies in which ovarian reserve parameters are measured repeatedly in the same individual before, during and after the use of oral contraceptives. Additionally, we need to explore the impact of dose-response and duration of hormonal contraception on markers of ovarian reserve," she said.

In their paper, the authors write: "Clearly, our data do not elucidate whether maternal age at menopause is a direct predictor of age at menopause of the offspring, or the chance of pregnancy. Nevertheless, from a biological point of view, it may be reasonable to assume that a low ovarian reserve may have a long-term effect that will shorten the reproductive lifespan. We therefore assume that markers such as ' at ' in combination with AMH or AFC, and chronological age may represent a more complete picture when evaluating the ovarian reserve of the individual. This assumption awaits before it can be put to test."

More information: "Maternal menopause as a predictor of anti-Mullerian hormone level and antral follicle count in daughters during reproductive age", by J.G. Bentzen, J.L. Forman, E.C. Larsen, A. Pinborg, T.H. Johannsen, L. Shmidt, L. Friis-Hansen, and A. Nyboe Andersen. Human Reproduction. doi:10.1093/humrep/des356

Related Stories

Study: Hormone level predicts end of fertility

May 26, 2011

The age-specific blood levels of the Anti-Mullerian hormone (AMH) can predict when women will reach menopause. This makes family planning easier, say fertility researchers from the University Medical Center Utrecht, The Netherlands. ...

Smoking fathers could lead to early menopausal daughters

Jun 03, 2011

According to a study published in Fertility and Sterility, men who smoke in the presence of their pregnant partner may be putting their unborn daughter at risk for early menopause by as much as a year. While other resear ...

New hormone data can predict menopause within a year

Oct 27, 2008

For many women, including the growing number who choose later-in-life pregnancy, predicting their biological clock's relation to the timing of their menopause and infertility is critically important.

Recommended for you

A hybrid vehicle that delivers DNA

7 hours ago

A new hybrid vehicle is under development. Its performance isn't measured by the distance it travels, but rather the delivery of its cargo: vaccines that contain genetically engineered DNA to fight HIV, cancer, ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.